{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:42Z","timestamp":1786120302084,"version":"build-2736575974"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/ogx.0b013e318234ede9","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T02:41:00Z","timestamp":1319683260000},"page":"507-514","source":"Crossref","is-referenced-by-count":33,"title":["Management of Malignant Ovarian Germ Cell Tumors"],"prefix":"10.1097","volume":"66","author":[{"given":"Christine A.","family":"Parkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thankamma V.","family":"Ajithkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00001703-199402000-00016","article-title":"Current approaches to diagnosis and treatment of ovarian germ cell malignancies.","volume":"6","author":"Fishman","year":"1994","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R2-17-20210212","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1991.180","article-title":"Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer.","volume":"63","author":"dos Santos Silva","year":"1991","journal-title":"Br J Cancer"},{"key":"R3-17-20210212","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2005.02.007","article-title":"Ovarian cancer incidence in the United States, 1992-1999.","volume":"97","author":"Quirk","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R4-17-20210212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.1988.171","article-title":"Benign ovarian teratomas: a population-based case-control study.","volume":"58","author":"Westhoff","year":"1988","journal-title":"Br J Cancer"},{"key":"R5-17-20210212","first-page":"511","article-title":"Practical Gynecologic Oncology.","author":"Berek","year":"2005"},{"key":"R6-17-20210212","first-page":"462","article-title":"Malignant germ cell tumors of the ovary and testis. An immunohistologic study of 69 cases.","volume":"9","author":"Kurman","year":"1979","journal-title":"Ann Clin Lab Sci"},{"key":"R7-17-20210212","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/bjc.1988.95","article-title":"Hormonal factors and risk of ovarian germ cell cancer in young women.","volume":"57","author":"Walker","year":"1988","journal-title":"Br J Cancer"},{"key":"R8-17-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19990507)84:1<43::AID-AJMG9>3.0.CO;2-2","article-title":"Familial ovarian germ cell cancer: report and review.","volume":"84","author":"Stettner","year":"1999","journal-title":"Am J Med Genet"},{"key":"R9-17-20210212","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008469-199908000-00005","article-title":"Oral contraceptives and ovarian cancer.","volume":"8","author":"La Vecchia","year":"1999","journal-title":"Eur J Cancer Prev"},{"key":"R10-17-20210212","article-title":"Pathology and Genetics of Tumours of the Breast and Female Organs.","author":"Tavassoli","year":"2003"},{"key":"R11-17-20210212","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0025-6196(12)62512-9","article-title":"Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity.","volume":"62","author":"Buskirk","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"R12-17-20210212","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00000478-198106000-00006","article-title":"Dysgerminoma with syncytiotrophoblastic giant cells. A histologically and clinically distinctive subtype of dysgerminoma.","volume":"5","author":"Zaloudek","year":"1981","journal-title":"Am J Surg Pathol"},{"key":"R13-17-20210212","first-page":"169","article-title":"Atlas of Tumor Pathology.","author":"Scully","year":"1998"},{"key":"R14-17-20210212","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/gyno.1995.1195","article-title":"Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype.","volume":"58","author":"Obata","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R15-17-20210212","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00006254-198602000-00002","article-title":"Neoplasia arising in dysgenetic gonads.","volume":"41","author":"Troche","year":"1986","journal-title":"Obstet Gynecol Surv"},{"key":"R16-17-20210212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1993.1201","article-title":"Five different histological subtypes of germ cell malignancies in an XY female.","volume":"50","author":"Bremer","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R17-17-20210212","first-page":"624","article-title":"Immature teratoma of the ovary.","volume":"68","author":"Gershenson","year":"1986","journal-title":"Obstet Gynecol"},{"key":"R18-17-20210212","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q","article-title":"Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases.","volume":"37","author":"Norris","year":"1976","journal-title":"Cancer"},{"key":"R19-17-20210212","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004347-199410000-00001","article-title":"The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading.","volume":"13","author":"O'Connor","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"R20-17-20210212","first-page":"597","article-title":"Gliomatosis peritonei with malignant transformation.","volume":"10","author":"Dadmanesh","year":"1997","journal-title":"Mod Pathol"},{"key":"R21-17-20210212","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2003.09.034","article-title":"Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst.","volume":"92","author":"Mengshol","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R22-17-20210212","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/00000478-199312000-00002","article-title":"New and unusual aspects of ovarian germ cell tumors.","volume":"17","author":"Young","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R23-17-20210212","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2559.1999.00650.x","article-title":"Ovarian hepatoid yolk sac tumors: morphological, immunohistochemical and ultrastructural features.","volume":"34","author":"Devouassoux-Shisheboran","year":"1999","journal-title":"Histopathology"},{"key":"R24-17-20210212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0020-7292(90)91025-L","article-title":"Embryonal carcinoma of the ovary: a six-year survival.","volume":"31","author":"Ueda","year":"1990","journal-title":"Int J Gynaecol Obstet"},{"key":"R25-17-20210212","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/1097-0142(197612)38:6<2420::AID-CNCR2820380630>3.0.CO;2-2","article-title":"Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis.","volume":"38","author":"Kurman","year":"1976","journal-title":"Cancer"},{"key":"R26-17-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3835(96)04219-X","article-title":"Gestational choriocarcinoma of the ovary diagnosed by analysis of tumor DNA.","volume":"104","author":"Lorigan","year":"1996","journal-title":"Cancer Lett"},{"key":"R27-17-20210212","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0090-8258(03)00139-2","article-title":"A pure nongestational choriocarcinoma of the ovary diagnosed with DNA polymorphism analysis.","volume":"89","author":"Tsujioka","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R28-17-20210212","first-page":"213","article-title":"Primary choriocarcinoma of the ovary. Report of two cases.","volume":"36","author":"Gangadharan","year":"1999","journal-title":"Indian J Cancer"},{"key":"R29-17-20210212","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/1097-0142(19820501)49:9<1878::AID-CNCR2820490922>3.0.CO;2-B","article-title":"Polyembryoma of ovary producing alpha-fetoprotein and HCG: immunoperoxidase and electron microscopic study.","volume":"49","author":"Takeda","year":"1982","journal-title":"Cancer"},{"key":"R30-17-20210212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0301-2115(98)00013-X","article-title":"Ovarian mixed germ cell tumor comprising polyembryoma and choriocarcinoma.","volume":"78","author":"Nishida","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R31-17-20210212","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004347-200201000-00015","article-title":"Ovarian mixed germ cell tumor with predominance of polyembryoma: a case report with literature review.","volume":"21","author":"Jondle","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R32-17-20210212","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/gyno.1998.5006","article-title":"Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.","volume":"69","author":"Takemori","year":"1998","journal-title":"Gynecol Oncol"},{"key":"R33-17-20210212","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1525-1438.2000.00010.x","article-title":"Experience of a 2-day BEP regimen in postsurgical adjuvant chemotherapy of ovarian germ cell tumors.","volume":"10","author":"Tay","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"R34-17-20210212","first-page":"200","article-title":"Mixed germ cell tumors of the ovary.","volume":"64","author":"Gershenson","year":"1984","journal-title":"Obstet Gynecol"},{"key":"R35-17-20210212","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2007.10.8738","article-title":"Management of ovarian germ cell tumors.","volume":"25","author":"Gershenson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"suppl 4","key":"R36-17-20210212","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/cncr.2820710425","article-title":"Update on malignant ovarian germ cell tumors.","volume":"71","author":"Gershenson","year":"1993","journal-title":"Cancer"},{"key":"R37-17-20210212","first-page":"235","article-title":"Management of malignant germ cell tumors of the ovary.","volume":"25","author":"Abu-Rustum","year":"1998","journal-title":"Semin Oncol"},{"key":"R38-17-20210212","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0090-8258(90)90425-K","article-title":"Alpha-fetoprotein in malignant germ cell tumors of the ovary.","volume":"39","author":"Kawai","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R39-17-20210212","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/172460089200700202","article-title":"Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors.","volume":"7","author":"Motawy","year":"1992","journal-title":"Int J Biol Markers"},{"key":"R40-17-20210212","first-page":"88","article-title":"Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.","volume":"46","author":"Ugrinska","year":"2002","journal-title":"Q J Nucl Med"},{"key":"R41-17-20210212","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0009-9120(01)00236-3","article-title":"A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.","volume":"34","author":"von Eyben","year":"2001","journal-title":"Clin Biochem"},{"key":"R42-17-20210212","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0090-8258(92)90058-Q","article-title":"Serum lactic dehydrogenase as a tumor marker in dysgerminoma.","volume":"44","author":"Pressley","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R43-17-20210212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/172460088800300307","article-title":"Tumour markers and POMB\/ACE chemotherapy in the management of ovarian germ cell tumors (GCTs).","volume":"3","author":"Newlands","year":"1988","journal-title":"Int J Biol Markers"},{"key":"R44-17-20210212","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jpedsurg.2004.05.023","article-title":"A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase.","volume":"39","author":"Tatekawa","year":"2004","journal-title":"J Pediatr Surg"},{"key":"R45-17-20210212","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0090-8258(92)90299-X","article-title":"Seven tumor markers in benign and malignant germ cell tumors of the ovary.","volume":"45","author":"Kawai","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R46-17-20210212","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0090-8258(89)80032-0","article-title":"Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma.","volume":"32","author":"Kawata","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R47-17-20210212","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/gyno.1997.4897","article-title":"Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.","volume":"68","author":"Suzuki","year":"1998","journal-title":"Gynecol Oncol"},{"key":"R48-17-20210212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0954-6111(97)90045-7","article-title":"Elevated serum angiotensin converting enzyme levels in metastatic ovarian dysgerminoma.","volume":"91","author":"Cotter","year":"1997","journal-title":"Respir Med"},{"key":"R49-17-20210212","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/rg.242035082","article-title":"Spectrum of germ cell tumors: from head to toe.","volume":"24","author":"Ueno","year":"2004","journal-title":"Radiographics"},{"key":"R50-17-20210212","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiographics.10.4.2165627","article-title":"From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation.","volume":"10","author":"Brammer","year":"1990","journal-title":"Radiographics"},{"key":"R51-17-20210212","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1148\/radiographics.12.5.1326777","article-title":"From the archives of the AFIP. Mediastinal germ cell tumors: radiologic and pathologic correlation.","volume":"12","author":"Rosado-de-Christenson","year":"1992","journal-title":"Radiographics"},{"key":"R52-17-20210212","first-page":"1135","article-title":"Gonadal mixed germ cell tumor combined with a large hemangiomatous lesion in a patient with Turner's syndrome and 45,X\/46,X, +mar karyotype.","volume":"118","author":"Tanaka","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"R53-17-20210212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/ajr.142.1.73","article-title":"CT of primary germ-cell tumors of the mediastinum.","volume":"142","author":"Levitt","year":"1984","journal-title":"Am J Roentgenol"},{"key":"R54-17-20210212","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00259-002-1075-z","article-title":"Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumors.","volume":"30","author":"Lassen","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R55-17-20210212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1479-828X.1999.tb03382.x","article-title":"Fertility and ovarian function after conservative surgery for germ cell tumors of the ovary.","volume":"39","author":"Perrin","year":"1999","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R56-17-20210212","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000421-200006000-00007","article-title":"Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.","volume":"23","author":"Kanazawa","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"R57-17-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1097-0142(20000715)89:2<391::AID-CNCR26>3.0.CO;2-V","article-title":"Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.","volume":"89","author":"Low","year":"2000","journal-title":"Cancer"},{"key":"R58-17-20210212","first-page":"128","article-title":"Malignant germ cell tumors of the ovary.","volume":"95","author":"Tewari","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R59-17-20210212","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2001.19.4.1015","article-title":"Survival and reproductive function after treatment of malignant germ cell ovarian tumors.","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"key":"R60-17-20210212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1097-0142(19850715)56:2<243::AID-CNCR2820560206>3.0.CO;2-T","article-title":"Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report).","volume":"56","author":"Slayton","year":"1985","journal-title":"Cancer"},{"key":"R61-17-20210212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-111-1-22","article-title":"Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.","volume":"111","author":"Williams","year":"1989","journal-title":"Ann Intern Med"},{"key":"R62-17-20210212","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gyno.1994.1049","article-title":"The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors.","volume":"52","author":"Gershenson","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R63-17-20210212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/gyno.1994.1050","article-title":"Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience.","volume":"52","author":"Williams","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R64-17-20210212","first-page":"355","article-title":"Surgery of germ cell tumors of the ovary.","volume":"10","author":"Schwartz","year":"2000","journal-title":"Forum (Genova)"},{"key":"R65-17-20210212","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1096-9098(199605)62:1<40::AID-JSO9>3.0.CO;2-R","article-title":"Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.","volume":"62","author":"Culine","year":"1996","journal-title":"J Surg Oncol"},{"issue":"4","key":"R66-17-20210212","first-page":"719","article-title":"Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary.","volume":"84","author":"Geisler","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R67-17-20210212","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1341-8076.2002.00032.x","article-title":"Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary.","volume":"28","author":"Itani","year":"2002","journal-title":"J Obstet Gynaecol Res"},{"key":"R68-17-20210212","first-page":"497","article-title":"Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.","volume":"58","author":"Gordon","year":"1981","journal-title":"Obstet Gynecol"},{"key":"R69-17-20210212","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.1997.15.2.620","article-title":"Surveillance policy for stage I ovarian germ cell tumors.","volume":"15","author":"Dark","year":"1997","journal-title":"J Clin Oncol"},{"key":"R70-17-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1525-1438.2007.00969.x","article-title":"A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites.","volume":"18","author":"Patterson","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R71-17-20210212","first-page":"598","article-title":"Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.","volume":"84","author":"Bonazzi","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R72-17-20210212","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1200\/JCO.2006.06.2489","article-title":"Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.","volume":"24","author":"Murugaesu","year":"2006","journal-title":"J Clin Oncol"},{"key":"R73-17-20210212","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.1994.12.4.701","article-title":"Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.","volume":"12","author":"Williams","year":"1994","journal-title":"J Clin Oncol"},{"key":"R74-17-20210212","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ygyno.2004.08.018","article-title":"Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.","volume":"95","author":"Dimopoulos","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R75-17-20210212","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.2006.07.7271","article-title":"Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.","volume":"25","author":"Einhorn","year":"2007","journal-title":"J Clin Oncol"},{"key":"R76-17-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/gyno.1994.1280","article-title":"Salvage surgery for chemorefractory ovarian germ cell tumors.","volume":"55","author":"Munkarah","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R77-17-20210212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/modpathol.3800978","article-title":"Malignant germ cell tumors in the elderly: a histopathological review of 50 cases in men aged 60 years or over.","volume":"21","author":"Berney","year":"2008","journal-title":"Mod Pathol"},{"key":"R78-17-20210212","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1200\/JCO.1997.15.7.2559","article-title":"Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.","volume":"15","author":"McCaffrey","year":"1997","journal-title":"J Clin Oncol"},{"key":"R79-17-20210212","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.1998.16.7.2500","article-title":"Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.","volume":"16","author":"Loehrer","year":"1998","journal-title":"J Clin Oncol"},{"key":"R80-17-20210212","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/annonc\/mdi228","article-title":"A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors.","volume":"16","author":"Pico","year":"2005","journal-title":"Ann Oncol"},{"key":"R81-17-20210212","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1200\/JCO.2005.19.638","article-title":"Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.","volume":"23","author":"Kondagunta","year":"2005","journal-title":"J Clin Oncol"},{"key":"R82-17-20210212","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0959-8049(95)00598-6","article-title":"Chemotherapy for ovarian germ cell tumors.","volume":"32A","author":"Bower","year":"1996","journal-title":"Eur J Cancer"},{"key":"R83-17-20210212","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.urolonc.2009.03.030","article-title":"Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.","volume":"29","author":"De Giorgi","year":"2011","journal-title":"Urol Oncol"},{"key":"R84-17-20210212","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.eururo.2009.09.039","article-title":"Re: Roisin M. Connolly, John A. McCaffrey. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. Eur Urol. 2009;56:57\u201364.","volume":"57","author":"Necchi","year":"2010","journal-title":"Eur Urol"},{"key":"R85-17-20210212","first-page":"569","article-title":"Malignant ovarian germ cell tumors: analysis of 32 cases.","volume":"24","author":"Yilmaz","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"key":"R86-17-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0360-3016(92)91036-M","article-title":"Dysgerminoma of the ovary: good prognosis even in advanced stages.","volume":"24","author":"Zaghloul","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R87-17-20210212","first-page":"384","article-title":"Survival and reproductive function after treatment of immature ovarian teratoma.","volume":"22","author":"Uzunlar","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"R88-17-20210212","first-page":"1496","article-title":"Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.","volume":"115","author":"Li","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"R89-17-20210212","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1067\/mob.2001.113323","article-title":"Prognostic factors of patients with yolk sac tumors of the ovary.","volume":"184","author":"Nawa","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R90-17-20210212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1200\/JCO.1988.6.2.270","article-title":"Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors.","volume":"6","author":"Gershenson","year":"1988","journal-title":"J Clin Oncol"},{"key":"R91-17-20210212","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.1999.17.9.2670","article-title":"Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.","volume":"17","author":"Brewer","year":"1999","journal-title":"J Clin Oncol"},{"key":"R92-17-20210212","first-page":"251","article-title":"Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.","volume":"101","author":"Tangir","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R93-17-20210212","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2008.20.9189","article-title":"Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.","volume":"27","author":"Matei","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Obstetrical &amp; Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006254-201108000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:41Z","timestamp":1786048001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006254-201108000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e318234ede9","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}